ESAB Corp
For the period ended Jul 4, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 4, 2025 · Filed Aug 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 31, 2025, the Company and Eleanor Lukens commenced the transition of her prior duties as President, Americas of the Company.
(c)Trading Plans
On May 16, 2025, Ms. Eleanor Lukens, President, Americas of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i)5,518 shares of Company common stock between August 15, 2025 and May 13, 2026, subject to certain conditions, all of which shares are to be acquired upon exercise of employee stock options and (ii) 2,770 shares of Company common stock between January 26, 2026 and May 13, 2026, subject to certain conditions.
On June 6, 2025, Mr. Kevin Johnson, Chief Financial Officer of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i)9,139 shares of Company common stock between September 8, 2025 and February 24, 2026, subject to certain conditions, all of which shares are to be acquired upon exercise of employee stock options scheduled to expire on February 24, 2026 and (ii) 7,300 shares of Company common stock between September 8, 2025 and February 22, 2027, subject to certain conditions, all of which shares are to be acquired upon exercise of employee stock options scheduled to expire on February 23, 2027.
On June 13, 2025, Mr. Shyam P. Kambeyanda, the President and Chief Executive Officer of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i)59,404 shares of Company common stock between September 15, 2025 and February 23, 2026, subject to certain conditions, all of which shares are to be acquired upon exercise of employee stock options scheduled to expire on February 24, 2026 and (ii) 9,286 shares of Company common stock between September 15, 2025 and February 27, 2026, subject to certain conditions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.